Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Mertajam leaf (Lepisanthes rubiginosa) contains flavonoids and polyphenols that inhibit inflammatory mediators like TNF-α and IL-6, providing anti-inflammatory and antipyretic effects. Preclinical studies demonstrate its antimicrobial activity and immune-modulating properties, though clinical trials in humans remain limited.
Reported Benefits (Provisional)
Origin & History
Mertajam (Lepisanthes rubiginosa) is a tree native to tropical lowland forests of Malaysia, Indonesia, and Thailand. Its leaves are traditionally valued in Southeast Asian folk medicine for their anti-inflammatory, immune-modulating, and fever-reducing properties.
Research Narrative (Provisional)
Research, including in vitro and animal studies, supports Mertajam leaf's anti-inflammatory, antioxidant, and antimicrobial properties. Evidence suggests its potential in immune modulation, fever reduction, and cardiovascular health, validating its traditional uses.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Flavonoids, Polyphenols, Tannins, Alkaloids, Saponins - Vitamins: Vitamin C - Minerals: Calcium, Iron, Potassium
Reported Mechanism (Provisional)
Flavonoids and polyphenolic compounds in Mertajam leaf inhibit pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β through NF-κB pathway suppression. The bioactive compounds demonstrate cyclooxygenase inhibition, reducing prostaglandin synthesis responsible for inflammation and fever. Antimicrobial effects appear to involve membrane disruption and enzyme inhibition in pathogenic microorganisms.
Clinical Narrative (Provisional)
Current evidence for Mertajam leaf relies primarily on in vitro and animal studies rather than human clinical trials. Laboratory studies demonstrate significant anti-inflammatory activity with IC50 values for cytokine inhibition, though specific quantified data varies across preparations. Animal models show fever reduction comparable to standard antipyretics, but human efficacy and optimal dosing remain unestablished. The evidence base is promising but requires controlled human trials to validate therapeutic applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.